You are here: Home » Marshall Protocol » Marshall Protocol medications
Home

Marshall Protocol medications

Brand (generic) Phases Dose Standard frequency Molecular activity Reported Half-life
Benicar (olmesartan)Medication taken regularly by patients on the Marshall Protocol for its ability to activate the Vitamin D Receptor. 1,2,3 40mg every 6 hours Vitamin D Receptor agonistA substance such as olmesartan (Benicar) or 125-D which activates the Vitamin D Receptor and transcribes the genes necessary for a proper innate immune response., anti-inflammatory 13 hours
Minocin (minocycline)Bacteriostatic antibiotic used by Marshall Protocol patients. 1,2,3 25-100mg every 2 days antibiotic – binds to the 30S ribosomal subunit; may bind to the PXR nuclear receptorIntracellular receptor proteins that bind to hydrophobic signal molecules (such as steroid and thyroid hormones) or intracellular metabolites and are thus activated to bind to specific DNA sequences which affects transcription. 11-22 hours
Zithromax (azithromycin)Bacteriostatic antibiotic used by Marshall Protocol patients. Has relatively long half-life. 2,3 12-125mg every 8-10 days antibiotic – binds to the 50S subunit of the bacterial ribosome reportedly 68 hours, but can remain in tissues for >1 month
clindamycinBacteriostatic antibiotic used by patients on the Marshall Protocol. 21),3 37.5mg-150mg every 2 days antibiotic – binds to the 50S subunit of the bacterial ribosome 2-3 hours
Bactrim DS (co-trimoxazole)Sulfa antibiotic used by patients on the Marshall Protocol. Combination of sulfamethoxazole and trimethoprim. Works by blocking bacterial folic acid synthesis. 3 125-1000mg every 2 days antibiotic – inhibits bacteria's ability to synthesize folate
Declomycin (demeclocycline)Bacteriostatic antibiotic used by patients on the Marshall Protocol. 3 37.5-150mg every 2 days antibiotic – binds to the 50S and 30S subunit of the bacterial ribosome 10-17 hours

For more details on how and when to use the Marshall ProtocolA curative medical treatment for chronic inflammatory disease. Based on the Marshall Pathogenesis. medications, consult the Phase One and Phase Two guidelines.

Notes and comments

EDIT

ramping level: mino (25mg) Note that the brand name for a drug (e.g. Benicar) is capitalized, and the substance name (e.g. olmesartanMedication taken regularly by patients on the Marshall Protocol for its ability to activate the Vitamin D Receptor. Also known by the trade name Benicar. ) is lower case.

References

1) Clindamycin is sometimes used as a part of the “Modified Phase Two”
home/mp/mpmeds.txt · Last modified: 01.29.2010 (external edit)
© 2010, Autoimmunity Research Foundation. All Rights Reserved.